In acute experimental autoimmune encephalomyelitis, infiltrating macrophages are immune activated, whereas microglia remain immune suppressed

GLIA

Volumn 62, Issue 10, 2014, Pages 1724-1735

  Vainchtein, I D ^a   Vinet, J ^b   Brouwer, N ^a   Brendecke, S ^c   Biagini, G ^b   Biber, K ^c   Boddeke, H W G M ^a   Eggen, B J L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

EAE; Ly 6C; Macrophage; Microglia; Multiple sclerosis

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD40 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 1BETA; LYMPHOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN 6 COMPLEX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CASP6 PROTEIN, MOUSE; CASPASE 6; CYTOKINE; IL1B PROTEIN, MOUSE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; PTPRC PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SELECTION; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FLOW CYTOMETRY; IMMUNE ACTIVATED; IMMUNE RESPONSE; IMMUNE SUPPRESSED; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MICROGLIA; MONOCYTE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHIMERA; DISEASE MODEL; IMMUNOLOGY; METABOLISM; SPINAL CORD; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD45; ANTIGENS, LY; CASPASE 6; CHIMERA; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERLEUKIN-1BETA; MACROPHAGES; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MULTIPLE SCLEROSIS; SPINAL CORD;

EID: 84906313533     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22711     Document Type: Article

References (38)

1. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM. 2011. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 14:1142-1149.
2. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204:1057-1069.
3. Bauer J, Huitinga I, Zhao W, Lassmann H, Hickey WF, Dijkstra CD. 1995. The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia 15:437-446.
4. Becher B, Bechmann I, Greter M. 2006. Antigen presentation in autoimmunity and CNS inflammation: How T lymphocytes recognize the brain. J Mol Med 84:532-543.
5. Benveniste EN. 1997a. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 75:165-173.
6. Benveniste EN. 1997b. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 75:165-173.
7. Biber K, Owens T, Boddeke E. 2014. What is microglia neurotoxicity (Not)? Glia. 62:841-854.
8. Brosnan CF, Bornstein MB, Bloom BR. 1981. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 126:614-620.
9. Carson MJ. 2002. Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis. Glia 40:218-231.
10. Cunningham C. 2013. Microglia and neurodegeneration: The role of systemic inflammation. Glia 61:71-90.
11. de Haas AH, Boddeke HW, Biber K. 2008. Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia 56:888-894.
12. Fife BT, Huffnagle GB, Kuziel W a, Karpus WJ. 2000. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 192:899-905.
13. Gandhi R, Laroni A, Weiner HL. 2010. Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 221:7-14.
14. Gold R, Linington C, Lassmann H. 2006. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129:1953-1971.
15. Goldmann T, Wieghofer P, Müller PF, Wolf Y, Varol D, Yona S, Brendecke SM, Kierdorf K, Staszewski O, Datta M, Luedde T, Heikenwalder M, Jung S, Prinz M. 2013. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat Neurosci 16:1618-1626.
16. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hövelmeyer N, Waisman A, Rülicke T, Prinz M, Priller J, Becher B, Aguzzi A. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11:146-152.
17. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193:713-726.
18. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD. 1990. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172:1025-1033.
19. Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD. 2000. Resistance to experimental autoimmune encephalomyelitis in mice lacking the Cc chemokine receptor (CCR2). J Exp Med 192:1075-1080.
20. Jack C, Ruffini F, Bar-Or A, Antel JP. 2005. Microglia and multiple sclerosis. J Neurosci Res 81:363-373.
21. Juedes AE, Hjelmström P, Bergman CM, Neild AL, Ruddle NH. 2000. Kinetics and cellular origin of cytokines in the central nervous system: Insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol 164:419-426.
22. Juedes AE, Ruddle NH. 2001. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol 166:5168-5175.
23. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
24. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H. 2005. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705-2712.
25. Lassmann H, Hickey WF. 1993. Radiation bone marrow chimeras as a tool to study microglia turnover in normal brain and inflammation. Clin Neuropathol 12:284-285.
26. Lassmann H, Brück W, Lucchinetti CF. 2007. The immunopathology of multiple sclerosis: An overview. Brain Pathol 17:210-218.
27. Lassmann H, van Horssen J. 2011. The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 585:3715-3723.
28. Melief J, Schuurman KG, van de Garde MDB, Smolders J, van Eijk M, Hamann J, Huitinga I. 2013. Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed. Glia 61:1848-1861.
29. Mildner A, Mack M, Schmidt H, Brück W, Djukic M, Zabel MD, Hille A, Priller J, Prinz M. 2009. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 132:2487-2500.
30. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, Heikenwalder M, Brück W, Priller J, Prinz M. 2007. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci 10:1544-1553.
31. Mizutani M, Pino PA, Saederup N, Charo IF, Ransohoff RM, Cardona AE. 2012. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J Immunol 188:29-36.
32. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318.
33. Olah M, Amor S, Brouwer N, Vinet J, Eggen B, Biber K, Boddeke HW. 2012. Identification of a microglia phenotype supportive of remyelination. Glia 60:306-321.
34. Ponomarev ED, Shriver LP, Maresz K, Dittel BN. 2005. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 81:374-389.
35. Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL. 2011. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. Nat Med 17:64-70.
36. Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou C-L, Ransohoff RM, Charo IF. 2010. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One 5:e13693.
37. Voss EV, Škuljec J, Gudi V, Skripuletz T, Pul R, Trebst C, Stangel M. 2012. Characterisation of microglia during de- and remyelination: Can they create a repair promoting environment? Neurobiol Dis 45:519-528.
38. Weiner HL. 2008. A shift from adaptive to innate immunity: A potential mechanism of disease progression in multiple sclerosis. J Neurol 255 Suppl:3-11.